OLR1 and Arterial thrombosis: Recent studies have found that plasma levels of sLOX-1 can predict fatal events at 1 year in ACS patients and JCAD can promote the formation of arterial thrombosis in STEMI patients by selectively regulating coagulation and fibrinolysis.